US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), Universite de Montpellier, Institut Regional du Cancer de Montpellier on Dec. 2 for "Combination for treating cancer" (French Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,126, issued on Dec. 2, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), Universite de Montpellier (Montpellier, France) and Institut Regional du Cancer de Montpellier (Montpellier, France).

"Combination for treating cancer" was invented by Antonio Maraver (Montpellier, France) and Emilie Bousquet (Montpellier, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the treatment of cancer and particularly of lung cancer. In the present study, the inventors analyzed the role of the Notch pathway in EGFR-driven lung adenocarcinoma (LUAD) using complex genetic mouse models and pat...